Open AccessComparative Cell‐Mediated Immunogenicity of DNA/DNA, DNA/Adenovirus Type 5 (Ad5), or Ad5/Ad5 HIV‐1 Clade BgagVaccine Prime‐Boost Regimens
Author(s) -
David M. Asmuth,
Elizabeth Levine Brown,
Mark J. DiNubile,
Xiao Sun,
Carlos del Rı́o,
Clayton Harro,
Michael C. Keefer,
James G. Kublin,
Sheri Dubey,
Lisa Kierstead,
Danilo R. Casimiro,
John W. Shiver,
Michael Robertson,
Erin Quirk,
Devan V. Mehrotra
Publication year - 2010
Publication title -
the journal of infectious diseases (online. university of chicago press)/the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/648591
Subject(s) - dna vaccination , elispot , immunogenicity , virology , hiv vaccine , adenoviridae , biology , immunology , immune system , medicine , vaccination , recombinant dna , cd8 , vaccine trial , immunization , gene , biochemistry
We report composite results from the Merck phase I program of near-consensus clade B human immunodeficiency virus (HIV) type 1 gag vaccines.